Related Experiment Video

Updated: May 3, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

915

Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure

Erik Tandberg Askevold1, Lars Gullestad, Christen P Dahl

  • 1Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, P.B. 4950 Nydalen, 0424, Oslo, Norway, erik.tandberg.askevold@rr-research.no.

Current Heart Failure Reports
|January 31, 2014
PubMed

Insights

Inflammation, particularly Interleukin-6 (IL-6) signaling via glycoprotein 130 (gp130), is linked to chronic heart failure (HF). Soluble gp130 (sgp130) may offer novel therapeutic strategies for HF.

Area of Science:

  • Cardiology
  • Immunology
  • Molecular Biology

Background:

  • Inflammation is increasingly recognized as a key factor in the development and worsening of chronic heart failure (HF).
  • While inflammatory markers predict risk in HF patients, the efficacy of anti-inflammatory treatments remains unclear.
  • Interleukin-6 (IL-6) type cytokines, signaling through the glycoprotein 130 (gp130) receptor, are central to inflammatory processes.

Purpose of the Study:

  • To review the current understanding of IL-6/gp130 signaling in the context of chronic heart failure.
  • To highlight the role of soluble gp130 (sgp130) as a modulator of this signaling pathway.
  • To explore potential therapeutic strategies targeting the IL-6/gp130 axis for HF management.

Main Methods:

  • Literature review of experimental and clinical evidence.
  • Analysis of the biological functions of IL-6 and sgp130.
  • Discussion of therapeutic implications.

Main Results:

  • IL-6/gp130 signaling represents a critical inflammatory pathway implicated in HF.
  • Soluble gp130 (sgp130) acts as a natural inhibitor and modulator of IL-6-type cytokine signaling.
  • Evidence suggests sgp130's potential role in mitigating inflammatory responses in HF.

Conclusions:

  • The IL-6/gp130 signaling pathway is a significant target for understanding and treating chronic heart failure.
  • Modulating this pathway, potentially through sgp130, offers promising avenues for novel anti-inflammatory therapies in HF.

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

4.9K
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

7.3K

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
56
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
1.2K